Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Luft

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Nature Communications|October 3, 2018
Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional declineMarco L Hennrich, Natalie Romanov, Patrick Horn, et al.
Annals of Hematology|June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantationStefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Bone Marrow Transplantation|April 13, 2024
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Frontiers in Immunology|April 6, 2019
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal PhotopheresisMing Ni, Lei Wang, Mingya Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Frontiers in Immunology|October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic EffectsLei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
Journal for Immunotherapy of Cancer|January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective studyOlaf Penack, Thomas Luft, Christophe Peczynski, et al.
Leukemia|December 22, 2018
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaJohannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Nature Communications|October 3, 2018
Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional declineMarco L Hennrich, Natalie Romanov, Patrick Horn, et al.
Annals of Hematology|June 5, 2026
What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantationStefan W Krause, Wolfgang Bethge, Gesine Bug, et al.
Bone Marrow Transplantation|April 13, 2024
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Frontiers in Immunology|April 6, 2019
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal PhotopheresisMing Ni, Lei Wang, Mingya Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Blood Advances|March 23, 2021
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantationNico Gagelmann, Anita Badbaran, Dietrich W Beelen, et al.
Frontiers in Immunology|October 24, 2018
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic EffectsLei Wang, Ming Ni, Angela Hückelhoven-Krauss, et al.
Journal for Immunotherapy of Cancer|January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective studyOlaf Penack, Thomas Luft, Christophe Peczynski, et al.
Leukemia|December 22, 2018
Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaJohannes Schetelig, Liesbeth C de Wreede, Michel van Gelder, et al.
Nature Communications|August 23, 2017
Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cellsSatish Ranjan, Alexander Goihl, Shrey Kohli, et al.
Pageof 12